Clinical trials recruiting for Obesity or Overweight
8
Recruiting trials
40
US states with sites
32
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 3 7
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| AZD6234 | 2 |
| Enicepatide | 2 |
| Mirikizumab | 2 |
| Tirzepatide | 2 |
| GZR18 injection,digoxin tablets, rosuvastatin calcium tablets and warfarin sodium tablets | 1 |
| Maridebart cafraglutide | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 7 |
| Pennsylvania | 7 |
| Texas | 7 |
| Alabama | 6 |
| Florida | 6 |
| Illinois | 6 |
| Missouri | 6 |
| North Carolina | 6 |
| Ohio | 6 |
| Washington | 6 |
| Georgia | 5 |
| Louisiana | 5 |
Top cities
San Antonio, Texas 6Houston, Texas 5Chicago, Illinois 4Columbus, Ohio 3Dothan, Alabama 3Kansas City, Missouri 3Las Vegas, Nevada 3Louisville, Kentucky 3Miami, Florida 3Milwaukee, Wisconsin 3
Self-screener
Recruiting trials
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection
Related conditions
Trials recruiting for Obesity or Overweight often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Obesity or Overweight trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.